TaiMed Biologics Inc. (4147)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
59. 50
-0.9
-1.4901%
NT$
21.49B Market Cap
- P/E Ratio
- Div Yield
1.11M Volume
- Eps
NT$ 60.4
Previous Close Want to track 4147 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TaiMed Biologics Inc. (4147) Statistics
Valuation metrics
Market Cap 21.49B
Enterprise value 16.05B
Trailing P/E (ttm) -120
Forward P/E -
PEG ratio -2.29
Price/Sales (ttm) 26.74
Price/Book (mrq) 4.49
Enterprise Value/Revenue 25.91
Enterprise Value/EBITDA -920.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 708.48K
Average volume (90 days) 1.11M
Price summary
52-Week low 47
52-Week high 76.8
Beta -
50-Day moving average 62.78
200-Day moving average 58.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 507:500
Last split Date 27 Feb 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.22%
Operating margin -0.3%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.96
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 15.48%
Book value per share (mrq) 13.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
